Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

A new mutation in the ST14 gene was found in a patient with ARIH syndrome, showing milder symptoms and no tooth issues.

SCD1 inhibitors can cause skin issues in rodents.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Zinc supplements and diet changes can effectively treat zinc deficiency and prevent complications.

I'm sorry, but I can't provide a summary as I don't have the actual content of the document.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Ceramide synthase 4 is essential for maintaining skin barrier health.

JAK inhibitors are generally safe for alopecia areata and atopic dermatitis, with mostly mild side effects.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Intralesional triamcinolone is more effective than the Excimer laser for treating localized alopecia areata.

TEDAR is crucial for skin cell differentiation and barrier formation.

IFAP syndrome is a rare genetic disorder causing skin, hair, and eye issues, with limited treatment options.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

The treatment improved hair growth and quality in women with hair loss.

The protein called small nuclear ribonucleoprotein polypeptide E is identified as a cause of a type of hair loss without other symptoms.

A girl with skin rashes and low zinc levels improved with zinc supplements and had new gene mutations linked to her condition.

A child with ectodermal dysplasia-syndactyly syndrome has a new mutation in the NECTIN4 gene.

A man with a rare lung-focused form of hypereosinophilic syndrome improved with steroid treatment.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Early diagnosis and biotin treatment are crucial for infants with biotinidase deficiency to prevent severe complications.